Dabur Ltd.(NSE: DABUR)|Q3 FY23 Results Out|Total Income falls 3% yoy

Dabur India Limited (NSE: DABUR) is a leading Indian consumer goods company founded in 1884. It is one of the largest Ayurvedic medicine and natural consumer product manufacturer in India. The company offers a wide range of products including health care, personal care, and food products. It operates globally with a presence in Asia, Africa, and the Middle East. The company’s popular brands include Dabur Amla, Real, Vatika, Honitus, and Babool, among others.

Dabur India Limited has reported a 3.4% growth in revenue for Q3FY23, reaching the Rs 3,000 crore mark for the first time in a quarter. Despite a challenging cost and operating environment, the company posted a constant currency growth of 5.7%. The net profit for the third quarter was Rs 476 crore with a 3-year compound annual growth rate (CAGR) of 6.1%. The CEO, Mr. Mohit Malhotra, stated that the company delivered steady results in a difficult environment, with India business reporting a growth of 3.3% and a 3-year CAGR of 9.5%.